Curewell completes majority recapitalization of AMR

Alliance for Multispecialty Research announced a majority recapitalization by Curewell alongside existing shareholders and management. The transaction was Curewell's first investment. AMR was a U.S. clinical research-site network, and the investment supported further expansion. No investment amount or precise ownership percentage was reported.